TherapeuticsMD (TXMD) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for TherapeuticsMD (TXMD) over the last 15 years, with Q3 2025 value amounting to -$5.6 million.
- TherapeuticsMD's Other Gross PP&E Adjustments rose 1229.88% to -$5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.6 million, marking a year-over-year increase of 1229.88%. This contributed to the annual value of -$6.1 million for FY2024, which is 988.04% up from last year.
- Per TherapeuticsMD's latest filing, its Other Gross PP&E Adjustments stood at -$5.6 million for Q3 2025, which was up 1229.88% from -$6.0 million recorded in Q2 2025.
- In the past 5 years, TherapeuticsMD's Other Gross PP&E Adjustments registered a high of -$4.2 million during Q3 2022, and its lowest value of -$10.6 million during Q2 2021.
- Its 5-year average for Other Gross PP&E Adjustments is -$6.0 million, with a median of -$6.0 million in 2025.
- In the last 5 years, TherapeuticsMD's Other Gross PP&E Adjustments crashed by 54184.7% in 2021 and then surged by 5864.19% in 2022.
- Quarter analysis of 5 years shows TherapeuticsMD's Other Gross PP&E Adjustments stood at -$8.0 million in 2021, then soared by 36.87% to -$5.1 million in 2022, then plummeted by 33.89% to -$6.8 million in 2023, then rose by 9.88% to -$6.1 million in 2024, then increased by 8.03% to -$5.6 million in 2025.
- Its last three reported values are -$5.6 million in Q3 2025, -$6.0 million for Q2 2025, and -$6.2 million during Q1 2025.